Fermenta Biotech Limited (BOM:506414)
India flag India · Delayed Price · Currency is INR
444.00
+11.40 (2.64%)
At close: Jul 27, 2026

Fermenta Biotech Cash Flow Statement

Millions INR. Fiscal year is Apr - Mar.

Operating Activities

Fiscal Year
FY 2026FY 2025FY 2024FY 2023FY 2022
Period Ending
Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
Net Income
717.65768.62-230.6-510.75154.47
Depreciation & Amortization
216.1240.87244.55277.83248.84
Other Amortization
0.871.312.654.646.78
Loss (Gain) From Sale of Assets
-1.0570.17381.26447.580.27
Stock-Based Compensation
29.53-1.91-10.1926.97
Provision & Write-off of Bad Debts
37.4811.728.565314.47
Other Operating Activities
11.8699.94318.1449.45156.41
Change in Accounts Receivable
-93.28-341.58-339.48353.07-170.17
Change in Inventory
-167.46-321.27427.5699.3127.94
Change in Accounts Payable
109.33137.9243.19-152.7131.3
Change in Other Net Operating Assets
67.31-258.66-4.23149.85-62.85
Operating Cash Flow
928.34409.021,0531,161434.41
Operating Cash Flow Growth
126.97%-61.17%-9.27%167.28%-30.60%

Investing Activities

Fiscal Year
FY 2026FY 2025FY 2024FY 2023FY 2022
Period Ending
Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
Capital Expenditures
-303.35-221.33-192.07-404.89-371.28
Sale of Property, Plant & Equipment
1.09192.510.650.460.91
Investment in Securities
-167.78-50.9740.34-163.938.81
Other Investing Activities
40.0778.2-3.914.2571.19
Investing Cash Flow
-429.96-1.6-154.97-554.09-260.38

Financing Activities

Fiscal Year
FY 2026FY 2025FY 2024FY 2023FY 2022
Period Ending
Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
Short-Term Debt Issued
122.09--22.915.97
Long-Term Debt Issued
4.3-30.54363.08243.05
Total Debt Issued
126.39-30.54386249.02
Short-Term Debt Repaid
--24.8-218.15--
Long-Term Debt Repaid
-193.36-347.94-518.17-552.37-225.96
Total Debt Repaid
-193.36-372.74-736.32-552.37-225.96
Net Debt Issued (Repaid)
-66.96-372.74-705.79-166.3723.06
Issuance of Common Stock
0.0724.67---
Repurchase of Common Stock
-172.82----
Common Dividends Paid
-72.92-36.12-36.09-42-72.12
Other Financing Activities
-110.25-124.47-166.64-205.43-166.73
Financing Cash Flow
-422.89-508.66-908.52-413.8-215.78

Net Cash Flow

Fiscal Year
FY 2026FY 2025FY 2024FY 2023FY 2022
Period Ending
Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
Miscellaneous Cash Flow Adjustments
--0-0.49-
Net Cash Flow
75.49-101.23-10.03193.69-41.75

Free Cash Flow

Fiscal Year
FY 2026FY 2025FY 2024FY 2023FY 2022
Period Ending
Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
Free Cash Flow
624.99187.69861.39756.1963.13
Free Cash Flow Growth
233.00%-78.21%13.91%1097.83%-13.83%
Free Cash Flow Margin
11.89%4.00%25.66%21.61%1.58%
Free Cash Flow Per Share
21.356.4329.8326.202.18
Levered Free Cash Flow
-646.5610.22158.24528.43-163.2
Unlevered Free Cash Flow
-574.4598.92264.78658.32-61.52

Additional Metrics

Fiscal Year
FY 2026FY 2025FY 2024FY 2023FY 2022
Period Ending
Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
Cash Interest Paid
110.25124.47166.64205.43166.73
Cash Income Tax Paid
164.2127.71-10.18-32.0893.08
Change in Working Capital
-84.1-783.62327.04449.52-173.78